Skip to main content
Crescentis Capital Limited logo

Crescentis Capital Limited — Investor Relations & Filings

Ticker · 511571 ISIN · INE754C01010 LEI · 33580023W5LHXJAVIC45 BSE.NS Financial and insurance activities
Open in API
Filings indexed 512 across all filing types
Latest filing 2025-11-13 Regulatory Filings
Country IN India
Listing BSE.NS 511571

About Crescentis Capital Limited

https://somdattfin.com/

Crescentis Capital Limited provides investment management and strategic financial advisory services. The firm specializes in identifying and executing high-growth investment opportunities to generate sustainable value. Core activities encompass portfolio management, corporate finance, and private equity operations. The organization utilizes analytical frameworks and market intelligence to support institutional and private clients in capital allocation and risk mitigation. Its operational model focuses on disciplined asset management, capital preservation, and the implementation of diversified investment strategies designed to optimize long-term performance.

Recent filings

Filing Released Lang Actions
Dear Stakeholders, Please find hereiwth attached News paper Advertisement regarding publication of Financial Results for the Quarter and half year ended 30th September, 2025.
Regulatory Filings Classification · 95% confidence The document is a communication from Som Datt Finance Corporation Ltd. dated November 13, 2025, addressed to BSE Limited. It references the newspaper publication of the company's un-audited financial results for the quarter and half year ended September 30, 2025. The document includes a subject line indicating it is about the newspaper publication of un-audited financial results, and it mentions Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates such disclosures. The text does not contain the actual financial statements or detailed financial analysis but rather states that copies of the newspaper publications of the un-audited financial results are enclosed. This suggests the document is an announcement of the publication of financial results rather than the full interim or quarterly report itself. Given the document length is 11,173 characters, it is not extremely short, but the content and context indicate it is a regulatory announcement of the publication of financial results, not the report itself. Therefore, the most appropriate classification is Regulatory Filings (RNS), as it is a general regulatory announcement about the publication of financial results without containing the substantive financial data or analysis required for an Interim/Quarterly Report (IR).
2025-11-13 English
The Company''s Financial Results for the quarter and half year ended on 30th September, 2025 along with a limited review report of the statutory auditor are enclosed.
Regulatory Filings
2025-11-12 English
With reference to our letter dated: 06th November, 2025 regarding board meeting intimation, pursuant to Regulation 30 of the SEBI LODR, we wish to inform you that the Board of Directors ....
Regulatory Filings
2025-11-12 English
Som Datt Finance Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 ,inter alia, to consider and approve prior Intimation ....
Regulatory Filings Classification · 95% confidence The document is a prior intimation to the stock exchange about an upcoming Board of Directors meeting scheduled to consider and approve the un-audited financial results for the quarter and half year ended 30th September 2025. It also mentions the introduction of an employee stock options scheme and other business. The document is a notice of a board meeting and does not contain actual financial results or detailed financial data. It is an announcement related to regulatory compliance under SEBI Listing Obligations and Disclosure Requirements. The document length is short (2138 characters), and it serves as a notification rather than a report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such regulatory announcements that do not fit other specific categories.
2025-11-06 English
Certificate under Reg 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the Quarter ended 30th September, 2025
Regulatory Filings
2025-10-17 English
Pursuant to provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 read with code of conduct for prevention of Insider Trading of the Company as amended from time to time, ....
Regulatory Filings Classification · 95% confidence The document is a short notice regarding the closure of the trading window for insiders and designated persons ahead of the Board Meeting to consider and approve unaudited financial results for the quarter and half year ending September 30, 2025. It is an announcement related to insider trading restrictions and does not contain any financial data or detailed report content. The document is only 1575 characters long and serves as a regulatory compliance announcement under SEBI regulations. Therefore, it is best classified as a Regulatory Filing (RNS), which is the fallback category for such compliance and procedural announcements that do not fit other specific categories.
2025-09-29 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.